Patent · US Active

Elimination of heterogeneous or mixed cell population in tumors

US8137669B2 · kind B2 · utility

7Cited by
2References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2008
Grant dateMar 20, 2012
Priority date
Expiry dateDec 7, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of killing or inhibiting tumors comprising of heterogeneous or mixed cell populations is described. The killing or inhibition of tumors is achieved by selectively targeting a unique ligand suspected of being expressed on a particular cell population to also kill a cell population lacking the unique ligand. These conjugates have therapeutic use as they are delivered to a specific cell population to kill these cells and the cytotoxic drug is released to kill non-targeted cells, thereby eliminating the tumor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.